Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis

Tirzepatide, a dual agonist of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide 1 (GLP-1) receptors, improved glucose control and reduced body weight in different therapeutic approaches. Herein, we overviewed the role of GIP and GLP-1 in the pathophysiology of type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Lisco, Giuseppe, De Tullio, Anna, Disoteo, Olga, De Geronimo, Vincenzo, Piazzolla, Giuseppina, De Pergola, Giovanni, Giagulli, Vito Angelo, Jirillo, Emilio, Guastamacchia, Edoardo, Sabbà, Carlo, Triggiani, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494570/
https://www.ncbi.nlm.nih.gov/pubmed/36157450
http://dx.doi.org/10.3389/fendo.2022.920541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494570/
https://www.ncbi.nlm.nih.gov/pubmed/36157450
http://dx.doi.org/10.3389/fendo.2022.920541

Ejemplares similares